Health and Wellness
Nyxoah is in the midst of a lawsuit brought on by Inspire Medical Systems alleging infringement of several patents related to its recently-cleared offering, Genio.
The company began trading on Nasdaq under the ticker symbol HTFL, opening at $19.00 per share.
Initiatives being introduced in Taiwan, Hong Kong, and Singapore use AI and mobile technologies.
The app-based programme, developed by Neuroscience Research Australia, helped reduce fall-related injuries by 20% in clinical trials.
The app has demonstrated 93% accuracy in a nationwide study involving nearly 1,800 seniors.
The Microdose GLP-1Rx Program will offer low-dose GLP-1 prescriptions combined with behavioral coaching, clinical monitoring and medication management.
The new law bans the use of AI for mental health and therapeutic decision-making, but states it can be used for administrative and supplementary support services.
The company began trading on the NYSE in May and saw an increase in its stock price upon the news of its second-quarter earnings.
The company aims to help providers secure stable pricing and access products and services for patients seeking reproductive and sexual healthcare.
The company will use the funds to scale its reach within the U.S. and to expand access to its offerings globally.